Abstract:Since its initial identification, the Forkhead Box P2 gene ( FOXP2 ) has maintained its singular status as the archetypal monogenic determinant implicated in Mendelian forms of human speech and language impairments. Despite the passage of two decades subsequent to its discovery, extant literature remains disproportionately sparse with regard to case-specific instances and loci of mutational perturbations. The objective of the current investigation centers on furnishing an enriched delineation of both its clinical manifestations and its mutational heterogeneity. Clinical phenotypes and peripheral blood samples were assiduously amassed from familial subjects. Whole-exome sequencing and Sanger sequencing methodologies were deployed for the unambiguous identification of potential genetic variants and for corroborating their co-segregation within the family pedigree. An exhaustive review of published literature focusing on patients manifesting speech and language disorders consequent to FOXP2 genetic anomalies was also undertaken. The investigation yielded the identification of a novel heterozygous variant, c.661del (p.L221Ffs*41), localized within the FOXP2 gene in the proband, an inheritance from his symptomatic mother. The proband presented with an array of symptoms, encompassing dysarthric speech, deficits in instruction comprehension, and communicative impediments. In comparison, the mother exhibited attenuated symptoms, including rudimentary verbalization capabilities punctuated by pronounced stuttering and dysarthria. A comprehensive analysis of articles archived in the Human Gene Mutation Database (HGMD) classified under "DM" disclosed the existence of 74 patients inclusive of the subjects under current examination, sub-divided into 19 patients with null variants, 5 patients with missense variants, and 50 patients with gross deletions or complex genomic rearrangements. A conspicuous predominance of delayed speech, impoverished current verbal abilities, verbal comprehension deficits, and learning difficulties were observed in patients harboring null or missense FOXP2 variants, as compared to their counterparts with gross deletions or complex rearrangements. Developmental delays, hypotonia, and craniofacial aberrations were exclusive to the latter cohort. The elucidated findings augment the existing corpus of knowledge on the genetic architecture influencing both the proband and his mother within this specified familial context. Of critical importance, these discoveries furnish a robust molecular framework conducive to the prenatal diagnostic evaluations of prospective progeny within this familial lineage.

Speech- and language-linked FOXP2 mutation targets protein motors in striatal neurons

Language fMRI abnormalities associated with FOXP2 gene mutation

Novel FOXP2 variant associated with speech and language dysfunction in a Chinese family and literature review

Foxp2 loss of function increases striatal direct pathway inhibition via increased GABA release

The role of cerebellar FOXP1 in the development of motor and communicative behaviors in mice

Expression of FoxP2 in the Basal Ganglia Regulates Vocal Motor Sequences in the Adult Songbird

Axon Guidance Pathways Served As Common Targets for Human Speech/language Evolution and Related Disorders.

Region-specific Foxp2 deletions in cortex, striatum or cerebellum cannot explain vocalization deficits observed in spontaneous global knockouts

Language-impaired children: No sign of the FOXP2 mutation

Early neuroimaging markers of FOXP2 intragenic deletion

Thalamocortical Dysconnectivity in Paroxysmal Kinesigenic Dyskinesia: Combining Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging

Compensation between FOXP transcription factors maintains proper striatal function

Assessing the effects of common variation in the FOXP2 gene on human brain structure

Case Report: FOXP1 Syndrome Caused by a De Novo Splicing Variant (c.1652+5 G>A) of the FOXP1 Gene.

TCF7L2 acts as a molecular switch in midbrain to control mammal vocalization through a transcriptional repression mechanism

New Horizons in the Study on the Biological Mechanism of Language: FOXP2 and Human Language Faculty

FOXP2 gene deletion and infant feeding difficulties: a case report

TCF7L2 Acts As a Molecular Switch in Midbrain to Control Mammal Vocalization Through Its DNA Binding Domain but Not Transcription Activation Domain

Mitochondrial dysfunction and oxidative stress contribute to cognitive and motor impairment in FOXP1 syndrome

FOXP1 regulates the development of excitatory synaptic inputs onto striatal neurons and induces phenotypic reversal with reinstatement

The language development via FOXP2 in autism spectrum disorder: A Review.